INDOCO REMEDIES LIMITED

Location

Maharashtra

Founded

1947-08-23

Risk Signals

86 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about INDOCO REMEDIES LIMITED

Live alerts from global media, monitored by Business Radar

ACUTAAS CHEMICALS vs INDOCO REMEDIES - Comparison Results

2025-07-07 (equitymaster.com)

ACUTAAS CHEMICALS vs INDOCO REMEDIES - Comparison Results

Make stock comparison and analysis on (543349 | AMIORG~EQ) with Indoco Remedies (532612 | INDOCO~EQ) online at Equitymaster.

Read more
Indoco Remedies Q4 Results: Shares fall 7% as company reports loss, revenue drops 12% - CNBC TV18

2025-05-22 (cnbctv18.com)

Indoco Remedies Q4 Results: Shares fall 7% as company reports loss, revenue drops 12% - CNBC TV18

Following the earnings announcement, shares of Indoco Remedies saw sharp fall. The stock fell over 12% from its day's high of ₹273.75 to hit a low of ₹240.25. As of 3:13 PM, the stock was trading at ₹242.40 on the BSE, down 7% for the day.

Read more
Stock Radar | Trendline breakout from declining channel makes Indoco Remedies an attractive buy: Shitij Gandhi -  Video | ET Now

2024-09-09 (economictimes.com)

Stock Radar | Trendline breakout from declining channel makes Indoco Remedies an attractive buy: Shitij Gandhi - Video | ET Now

"Indoco Remedies stock has given a fresh breakout above the inverted head & shoulder pattern on short-term charts while trend line breakout above the declining channel has also been observed on broader charts with rising volumes. Traders can buy for a target of Rs 425-430 in the next 5-7 weeks," Shitij Gandhi, Senior Technical Analyst, SMC Global Securities, said.

Read more
Indoco Remedies Q3 Results Review - Another Quarter Of Weak Margins: Prabhudas Lilladher

2024-01-24 (ndtvprofit.com)

Indoco Remedies Q3 Results Review - Another Quarter Of Weak Margins: Prabhudas Lilladher

Indoco Remedies Ltd.'s cut our FY25/FY26 earning per share by ~10%/4% to factor in low margins and lower sales across regulated markets. We downgrade stock from Buy to 'Accumulate' given weak earnings visibility, muted domestic formulation sales. Our numbers do factor in margin recovery with reduction in remediation cost from FY25. Indoco Remedies Q3 FY24 Ebitda was sharply below our estimates led by continued higher remediation cost and lower regulated market sales.

Read more
Mid-cap Picks With Anil Singhvi: JBM Auto, Indoco Remedies, Thyrocare are stocks to buy for high returns

2020-09-12 (zeebiz.com)

Mid-cap Picks With Anil Singhvi: JBM Auto, Indoco Remedies, Thyrocare are stocks to buy for high returns

Mid-cap Picks With Anil Singhvi: Amid Indian stocks closely following Wall Street and other global stock markets, Zee Business Managing Editor Anil Singhvi has been busy recommending various stock picks with his panel of experts. Get more India News and Business News on Zee Business.

Read more
Indoco Remedies Faces Significant Stock Decline Amid Broader Market Challenges

(marketsmojo.com)

Indoco Remedies Faces Significant Stock Decline Amid Broader Market Challenges

Indoco Remedies, a small-cap pharmaceutical company, has faced a notable decline in its stock price, underperforming against its sector. The company has experienced significant volatility and is trading below key moving averages, reflecting ongoing challenges. Year-to-date, its performance contrasts sharply with broader market trends.

Read more
Indoco Remedies Ltd Share Price Today, INDOCO Share Price NSE, BSE

(businesstoday.in)

Indoco Remedies Ltd Share Price Today, INDOCO Share Price NSE, BSE

Indoco Remedies Ltd Share price NSE, BSE today: check share/stock price of INDOCO, get live NSE/BSE stock price of Indoco Remedies Ltd with financial reports, peer comparisons, stock performance, about company, shareholding pattern, SWOT analysis on Business Today.

Read more

Never miss a headline about INDOCO REMEDIES LIMITED

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages